EDGAR Filing Documents for 0001171843-18-005581

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-18-005581

Filing Date

2018-08-01

Accepted

2018-07-31 20:02:46

Documents

Period of Report

2018-07-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_073118.htm	6-K	11308
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	8174
3	EXHIBIT 99.2	exh_992.htm	EX-99.2	277973
4	EXHIBIT 99.3	exh_993.htm	EX-99.3	1807
5	GRAPHIC	logo.jpg	GRAPHIC	28757
6	GRAPHIC	perf_graph.jpg	GRAPHIC	56903
7	GRAPHIC	proxy_1.jpg	GRAPHIC	74279
8	GRAPHIC	proxy_2.jpg	GRAPHIC	75805
	Complete submission text file	0001171843-18-005581.txt		625444

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 450-686-4555

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)